US Stock MarketDetailed Quotes

Soleno Therapeutics (SLNO)

Watchlist
  • 52.720
  • -0.110-0.21%
Close Apr 24 15:59 ET
  • 52.720
  • 0.0000.00%
Post 20:01 ET
2.73BMarket Cap135.18P/E (TTM)

Soleno Therapeutics (SLNO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
167.73%46.8M
303.01%48.7M
391.13%43.45M
28.57%-12.61M
-161.43%-32.75M
-177.05%-69.1M
-279.97%-23.99M
-135.72%-14.93M
-217.12%-17.65M
-86.21%-12.53M
Net income from continuing operations
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Depreciation and amortization
1.51%2.02M
1.19%509K
0.40%502K
1.62%502K
2.86%504K
1.48%1.99M
2.86%503K
2.04%500K
1.02%494K
0.00%490K
Other non cash items
68.07%6.2M
85.69%973K
-23.30%757K
-24.33%1.29M
576.76%3.17M
21.45%3.69M
-54.40%524K
-9.20%987K
320.20%1.71M
19.34%469K
Change In working capital
-509.32%-24.63M
-345.88%-6.42M
18.88%6.56M
-355.42%-18.42M
-427.80%-6.36M
105.53%6.02M
36.96%2.61M
5,526.53%5.51M
-598.64%-4.04M
1,600.88%1.94M
-Change in receivables
---28.21M
---2.7M
---882K
----
----
--0
--0
--0
----
----
-Change in inventory
---14.03M
---8.02M
---3.92M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-531.73%-4.74M
-235.37%-3.45M
-838.61%-948K
929.10%3.08M
-4,317.28%-3.42M
10.39%-750K
-55.91%-1.03M
-189.38%-101K
579.55%299K
124.25%81K
-Change in payables and accrued expense
16.41%8.51M
70.17%6.72M
0.79%4.36M
143.51%1.27M
-295.97%-3.84M
158.23%7.31M
166.80%3.95M
859.65%4.33M
-576.51%-2.92M
49.47%1.96M
-Change in other current liabilities
2,637.80%13.83M
438.64%1.04M
3,053.18%9.43M
664.91%2.46M
997.00%897K
-158.41%-545K
-133.88%-308K
34.68%299K
-50.34%-436K
-208.70%-100K
-Change in other working capital
----
----
----
----
----
----
----
278.08%1.26M
107.88%923K
-100.10%-1.91M
Cash from discontinued investing activities
Operating cash flow
167.73%46.8M
303.01%48.7M
391.13%43.45M
28.57%-12.61M
-161.43%-32.75M
-177.05%-69.1M
-279.97%-23.99M
-135.72%-14.93M
-217.12%-17.65M
-86.21%-12.53M
Investing cash flow
Cash flow from continuing investing activities
10.59%-201.78M
-2,045.68%-125.36M
-2,363.44%-91.44M
93.45%-7.92M
119.90%22.94M
-225.68M
6.44M
4.04M
-120.92M
-115.24M
Net PPE purchase and sale
66.51%-73K
-625.00%-58K
99.48%-1K
-12.50%-9K
54.55%-5K
---218K
---8K
---191K
---8K
---11K
Net investment purchase and sale
10.54%-201.71M
-2,042.37%-125.3M
-2,261.24%-91.44M
93.46%-7.91M
119.91%22.94M
---225.46M
--6.45M
--4.23M
---120.91M
---115.23M
Cash from discontinued investing activities
Investing cash flow
10.59%-201.78M
-2,045.68%-125.36M
-2,363.44%-91.44M
93.45%-7.92M
119.90%22.94M
---225.68M
--6.44M
--4.04M
---120.92M
---115.24M
Financing cash flow
Cash flow from continuing financing activities
-35.61%137.16M
-275.07%-99.9M
9,489.19%218.15M
-89.73%15.69M
243.07%3.22M
18.33%213.03M
-53.82%57.06M
-94.23%2.28M
795.36%152.75M
938K
Net issuance payments of debt
--0
----
----
----
----
--49.89M
----
----
----
----
Net common stock issuance
-22.41%115.58M
---100.15M
33,965.15%215.72M
----
----
8.05%148.96M
--0
-122.18%-637K
----
----
Proceeds from stock option exercised by employees
57.87%22.39M
-86.70%954K
-22.56%2.26M
403.64%15.9M
249.68%3.28M
-66.36%14.18M
27.37%7.18M
-92.03%2.91M
--3.16M
--938K
Net other financing activities
---803K
---708K
--178K
---211K
---62K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-35.61%137.16M
-275.07%-99.9M
9,489.19%218.15M
-89.73%15.69M
243.07%3.22M
18.33%213.03M
-53.82%57.06M
-94.23%2.28M
795.36%152.75M
--938K
Net cash flow
Beginning cash position
-48.18%87.93M
409.50%246.66M
34.15%76.5M
89.82%81.33M
-48.18%87.93M
1,062.04%169.68M
-7.67%48.41M
194.42%57.02M
444.16%42.85M
1,062.04%169.68M
Current changes in cash
78.20%-17.82M
-546.81%-176.56M
2,076.14%170.17M
-134.10%-4.83M
94.80%-6.6M
-152.72%-81.75M
-66.30%39.52M
-126.04%-8.61M
23.34%14.18M
-1,785.17%-126.83M
End cash Position
-20.27%70.11M
-20.27%70.11M
409.50%246.66M
34.15%76.5M
89.82%81.33M
-48.18%87.93M
-48.18%87.93M
-7.67%48.41M
194.42%57.02M
444.16%42.85M
Free cash flow
167.41%46.73M
302.70%48.65M
387.44%43.45M
28.55%-12.62M
-161.24%-32.76M
-177.92%-69.31M
-280.09%-24M
-138.74%-15.12M
-217.27%-17.66M
-86.37%-12.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 167.73%46.8M303.01%48.7M391.13%43.45M28.57%-12.61M-161.43%-32.75M-177.05%-69.1M-279.97%-23.99M-135.72%-14.93M-217.12%-17.65M-86.21%-12.53M
Net income from continuing operations 111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Depreciation and amortization 1.51%2.02M1.19%509K0.40%502K1.62%502K2.86%504K1.48%1.99M2.86%503K2.04%500K1.02%494K0.00%490K
Other non cash items 68.07%6.2M85.69%973K-23.30%757K-24.33%1.29M576.76%3.17M21.45%3.69M-54.40%524K-9.20%987K320.20%1.71M19.34%469K
Change In working capital -509.32%-24.63M-345.88%-6.42M18.88%6.56M-355.42%-18.42M-427.80%-6.36M105.53%6.02M36.96%2.61M5,526.53%5.51M-598.64%-4.04M1,600.88%1.94M
-Change in receivables ---28.21M---2.7M---882K----------0--0--0--------
-Change in inventory ---14.03M---8.02M---3.92M----------0--0--0--------
-Change in prepaid assets -531.73%-4.74M-235.37%-3.45M-838.61%-948K929.10%3.08M-4,317.28%-3.42M10.39%-750K-55.91%-1.03M-189.38%-101K579.55%299K124.25%81K
-Change in payables and accrued expense 16.41%8.51M70.17%6.72M0.79%4.36M143.51%1.27M-295.97%-3.84M158.23%7.31M166.80%3.95M859.65%4.33M-576.51%-2.92M49.47%1.96M
-Change in other current liabilities 2,637.80%13.83M438.64%1.04M3,053.18%9.43M664.91%2.46M997.00%897K-158.41%-545K-133.88%-308K34.68%299K-50.34%-436K-208.70%-100K
-Change in other working capital ----------------------------278.08%1.26M107.88%923K-100.10%-1.91M
Cash from discontinued investing activities
Operating cash flow 167.73%46.8M303.01%48.7M391.13%43.45M28.57%-12.61M-161.43%-32.75M-177.05%-69.1M-279.97%-23.99M-135.72%-14.93M-217.12%-17.65M-86.21%-12.53M
Investing cash flow
Cash flow from continuing investing activities 10.59%-201.78M-2,045.68%-125.36M-2,363.44%-91.44M93.45%-7.92M119.90%22.94M-225.68M6.44M4.04M-120.92M-115.24M
Net PPE purchase and sale 66.51%-73K-625.00%-58K99.48%-1K-12.50%-9K54.55%-5K---218K---8K---191K---8K---11K
Net investment purchase and sale 10.54%-201.71M-2,042.37%-125.3M-2,261.24%-91.44M93.46%-7.91M119.91%22.94M---225.46M--6.45M--4.23M---120.91M---115.23M
Cash from discontinued investing activities
Investing cash flow 10.59%-201.78M-2,045.68%-125.36M-2,363.44%-91.44M93.45%-7.92M119.90%22.94M---225.68M--6.44M--4.04M---120.92M---115.24M
Financing cash flow
Cash flow from continuing financing activities -35.61%137.16M-275.07%-99.9M9,489.19%218.15M-89.73%15.69M243.07%3.22M18.33%213.03M-53.82%57.06M-94.23%2.28M795.36%152.75M938K
Net issuance payments of debt --0------------------49.89M----------------
Net common stock issuance -22.41%115.58M---100.15M33,965.15%215.72M--------8.05%148.96M--0-122.18%-637K--------
Proceeds from stock option exercised by employees 57.87%22.39M-86.70%954K-22.56%2.26M403.64%15.9M249.68%3.28M-66.36%14.18M27.37%7.18M-92.03%2.91M--3.16M--938K
Net other financing activities ---803K---708K--178K---211K---62K--------------------
Cash from discontinued financing activities
Financing cash flow -35.61%137.16M-275.07%-99.9M9,489.19%218.15M-89.73%15.69M243.07%3.22M18.33%213.03M-53.82%57.06M-94.23%2.28M795.36%152.75M--938K
Net cash flow
Beginning cash position -48.18%87.93M409.50%246.66M34.15%76.5M89.82%81.33M-48.18%87.93M1,062.04%169.68M-7.67%48.41M194.42%57.02M444.16%42.85M1,062.04%169.68M
Current changes in cash 78.20%-17.82M-546.81%-176.56M2,076.14%170.17M-134.10%-4.83M94.80%-6.6M-152.72%-81.75M-66.30%39.52M-126.04%-8.61M23.34%14.18M-1,785.17%-126.83M
End cash Position -20.27%70.11M-20.27%70.11M409.50%246.66M34.15%76.5M89.82%81.33M-48.18%87.93M-48.18%87.93M-7.67%48.41M194.42%57.02M444.16%42.85M
Free cash flow 167.41%46.73M302.70%48.65M387.44%43.45M28.55%-12.62M-161.24%-32.76M-177.92%-69.31M-280.09%-24M-138.74%-15.12M-217.27%-17.66M-86.37%-12.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More